Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
CA approval not obtained
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to compare different up-dosing schedules with Osiris.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| OSIRIS | Active Comparator |
| |
| OSIRIS other concentration 1 | Experimental |
| |
| OSIRIS other concentration 2 | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| OSIRIS | Drug | OSIRIS current practice |
| |
| OSIRIS other concentration 1 |
| Measure | Description | Time Frame |
|---|---|---|
| evaluate the tolerability of different up-dosing schedules | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| patient's satisfaction | 30 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Krakow | Poland |
Not provided
| ID | Term |
|---|---|
| D065631 | Rhinitis, Allergic |
| D012220 | Rhinitis |
| ID | Term |
|---|---|
| D009668 | Nose Diseases |
| D012140 | Respiratory Tract Diseases |
| D012130 | Respiratory Hypersensitivity |
| D010038 | Otorhinolaryngologic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C583319 | Osi21 protein, Drosophila |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
OSIRIS new concentration 1 |
|
| OSIRIS other concentration 2 | Drug | OSIRIS new concentration 2 |
|
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |